GlassScriptPhysician profile
Babak Baseri
NPI 1659716959
$30,730.82
in general payments reported to CMS, 2019-2025
98 companies · $6,646 in 2025
The $6,646 reported for 2025 was more than what 85% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $2,914 · 2021: $3,874 · 2022: $4,519 · 2023: $5,126 · 2024: $6,574 · 2025: $6,646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Long Term Medical Supply Or Device Loan: $2,196 · Education: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,284.73 |
| Long Term Medical Supply Or Device Loan | $2,196.36 |
| Education | $864.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,499.26 | 2019-2025 | |
| Janssen Biotech, INC. | $1,751.82 | 2019-2025 | Erleada, Rybrevant, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $1,654.80 | 2019-2025 | Imfinzi, Calquence, Lynparza |
| Pfizer INC. | $1,344.68 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,204.54 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $1,051.32 | 2020-2025 | Jakafi, Monjuvi |
| Celgene Corporation | $1,020.02 | 2020-2025 | Reblozyl, Pomalyst, Opdivo |
| Eisai INC. | $991.88 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $962.34 | 2019-2025 | Alunbrig, Fruzaqla, Iclusig |
| E.R. Squibb & Sons, L.L.C. | $913.08 | 2020-2025 | Opdualag, Reblozyl, Opdivo |
| Pharmacyclics LLC, An Abbvie Company | $867.71 | 2019-2023 | Imbruvica, Epkinly |
| Amgen INC. | $720.65 | 2019-2025 | Vectibix, Nplate, Lumakras |
| Glaxosmithkline, LLC. | $692.28 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Alexion Pharmaceuticals, INC. | $608.22 | 2019-2025 | Ultomiris |
| Astellas Pharma US INC | $574.75 | 2019-2025 | Xospata, Vyloy, Padcev |
Show all 98 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $557.09 | 2020-2025 | Enhertu, Injectafer, Vanflyta |
| Karyopharm Therapeutics INC. | $522.44 | 2020-2025 | Xpovio |
| Bayer Healthcare Pharmaceuticals INC. | $520.28 | 2021-2025 | |
| Abbvie INC. | $475.70 | 2020-2025 | |
| Genentech USA, INC. | $466.74 | 2019-2025 | Polivy, Venclexta, Lunsumio |
| Rigel Pharmaceuticals, INC. | $432.10 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Regeneron Healthcare Solutions, INC. | $428.19 | 2021-2025 | Libtayo |
| Gilead Sciences, INC. | $406.19 | 2021-2025 | Trodelvy |
| Kite Pharma, INC. | $406.13 | 2021-2025 | Yescarta |
| Genzyme Corporation | $394.54 | 2019-2025 | |
| Lilly USA, LLC | $364.96 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Csl Behring | $359.03 | 2019-2024 | Afstyla, Idelvion |
| Puma Biotechnology, INC. | $353.07 | 2019-2025 | |
| Seagen INC. | $333.05 | 2020-2023 | Padcev |
| Array Biopharma INC | $312.58 | 2021-2025 | Braftovi, Mektovi, Tukysa |
| Sobi, INC | $309.00 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $300.91 | 2019-2025 | Onivyde, Tazverik, Somatuline Depot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $270.38 | 2020-2025 | Gilotrif |
| Beigene USA, INC. | $261.81 | 2020-2024 | Brukinsa |
| Epizyme, INC. | $252.77 | 2020-2022 | |
| Exelixis INC. | $236.42 | 2019-2025 | Cabometyx |
| Taiho Oncology, INC. | $226.69 | 2019-2025 | |
| Blueprint Medicines Corporation | $206.51 | 2020-2024 | Ayvakit |
| Dendreon Pharmaceuticals LLC | $206.19 | 2023-2025 | Provenge |
| Foundation Medicine, INC. | $153.47 | 2020-2023 | |
| Agios Pharmaceuticals, INC. | $146.68 | 2020-2024 | Pyrukynd |
| Mirati Therapeutics, INC. | $137.36 | 2023-2024 | Krazati |
| Dova Pharmaceuticals | $134.69 | 2019-2021 | |
| Morphosys, US INC. | $133.52 | 2021-2023 | Monjuvi |
| Emd Serono, INC. | $130.36 | 2020-2025 | Bavencio |
| Jazz Pharmaceuticals INC. | $128.87 | 2020-2025 | |
| Secura Bio, INC. | $120.75 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $117.43 | 2023-2025 | Sylvant, Enjaymo |
| Tempus Ai, INC | $113.38 | 2024 | |
| Pharmaessentia USA Corporation | $108.36 | 2023-2025 | Besremi |
| Tersera Therapeutics LLC | $103.94 | 2023-2025 | Zoladex |
| Stemline Therapeutics INC. | $86.84 | 2023-2025 | Orserdu, Elzonris |
| Verity Pharmaceuticals INC. | $77.35 | 2022-2025 | Trelstar |
| Aveo Pharmaceuticals, INC. | $72.71 | 2022-2025 | Fotivda |
| Deciphera Pharmaceuticals INC. | $72.02 | 2020-2025 | Qinlock, Romvimza |
| Geron Corporation | $69.87 | 2025 | Rytelo |
| Kyowa Kirin, INC. | $67.96 | 2019-2021 | |
| Novocure INC. | $67.40 | 2020-2025 | Optune Lua (Novottf-200t) |
| Adaptive Biotechnologies Corporation | $64.21 | 2022 | |
| Adc Therapeutics America, INC. | $59.84 | 2024-2025 | |
| Eusa Pharma (US) LLC | $59.68 | 2022 | |
| Beone Medicines USA, INC. | $52.89 | 2025 | Brukinsa |
| Mylan Institutional INC. | $49.27 | 2019-2020 | |
| Octapharma USA, INC. | $49.07 | 2022 | |
| Verastem, INC. | $47.73 | 2019-2020 | |
| Servier Pharmaceuticals LLC | $47.15 | 2022-2024 | |
| Tesaro, INC. | $43.94 | 2019 | |
| Progenics Pharmaceuticals, INC. | $42.80 | 2022-2023 | Pylarify |
| Aurobindo Pharma USA, INC. | $36.21 | 2020 | |
| Mallinckrodt Hospital Products INC. | $33.51 | 2022 | |
| Iovance Biotherapeutics, INC. | $30.68 | 2025 | Amtagvi |
| Myovant Sciences INC. | $29.99 | 2021 | |
| Cti Biopharma Corp. | $29.85 | 2022 | |
| Advanced Accelerator Applications | $29.47 | 2020 | |
| Springworks Therapeutics, INC. | $28.06 | 2024 | Ogsiveo |
| Azurity Pharmaceuticals, INC. | $27.87 | 2025 | Danziten |
| Caris Mpi, INC. | $27.62 | 2025 | Mi Cancer Seek |
| Macrogenics, INC. | $26.66 | 2021 | |
| Ge Healthcare | $26.59 | 2021 | |
| Immunogen, INC. | $26.00 | 2023 | Elahere |
| Amag Pharmaceuticals, INC. | $24.94 | 2021 | |
| Partner Therapeutics, INC. | $24.54 | 2020 | |
| Coherus Oncology, INC. | $23.48 | 2020 | |
| Sirtex Medical INC | $23.35 | 2024 | Sir-Spheres Microspheres |
| Fennec Pharmaceuticals, INC. | $23.27 | 2024 | Pedmark |
| Acceleron Pharma, INC. | $21.74 | 2021 | |
| Pharmacosmos Therapeutics INC. | $21.16 | 2024 | Cosela |
| Nestle Healthcare Nutrition INC. | $20.75 | 2023 | |
| Sanofi-Aventis U.S. LLC | $19.92 | 2021 | |
| Accord Healthcare, INC. | $19.11 | 2024 | |
| Alnylam Pharmaceuticals INC. | $18.89 | 2022 | |
| Tg Therapeutics, INC. | $18.61 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.93 | 2020 | |
| Telix Pharmaceuticals | $17.78 | 2023 | Illuccix |
| Emmaus Medical, INC. | $16.88 | 2022 | |
| Apellis Pharmaceuticals, INC. | $16.58 | 2025 | Empaveli |
| Acrotech Biopharma INC. | $15.42 | 2021 | |
| Myriad Genetic Laboratories, INC. | $14.30 | 2021 |
Drugs and devices associated with these payments
Kisqali $2,661Imbruvica $684Lenvima $673Keytruda $643Reblozyl $540Erleada $478Enhertu $402Rybrevant $390Jakafi $350Xpovio $350Ultomiris $349Nubeqa $333Imfinzi $310Lynparza $307Jemperli $287Libtayo $279Vitrakvi $277Stivarga $277Zejula $272Scemblix $253Opdualag $241Doptelet $224Lutathera $215Tivdak $214Tavalisse $210Rezlidhia $210Provenge $206Mektovi $203Braftovi $203Alunbrig $191Brukinsa $183Adcetris $181Welireg $178Xtandi $169Xospata $163Padcev $161Piqray $160Calquence $158Verzenio $155Jaypirca $155Epkinly $152Tukysa $151Orgovyx $150Elrexfio $145Ojjaara $139Krazati $137Onivyde $136Idelvion $134Afstyla $134Talzenna $133Tazverik $131Monjuvi $129Ayvakit $119Venclexta $115Yescarta $114Polivy $114Opdivo $113Fruzaqla $110Besremi $108Cabometyx $107Bosulif $107Pyrukynd $105Zoladex $104Iclusig $102Carvykti $101Inqovi $100Lonsurf $100Trodelvy $98.68Vyloy $92.35Fabhalta $91.28Lorbrena $89.49Pluvicto $88.96Sylvant $72.85Tecvayli $70.18Talvey $70.18Rytelo $69.87Lunsumio $66.43Xalkori $66.07Oxbryta $64.51Ibrance $63.47Orserdu $62.39Pomalyst $61.02Promacta $58.48Itovebi $56.20Balversa $55.42Akeega $55.42Qinlock $52.27Trelstar $50.11Mekinist $44.84Enjaymo $44.58Nerlynx $44.28Vonjo $42.62Synagis $41.90Somatuline Depot $41.36Tagrisso $40.69Darzalex $40.11Fotivda $38.54Retevmo $35.84Ninlaro $35.80Illuccix $35.56
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Baseri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.